Works matching IS 03331024 AND DT 2022 AND VI 42 AND IP 4/5

Results: 17

Board Walk - April 2022.

Published in:

2022

By:

Pozo-Rosich, Patricia

Publication type:

Editorial

Board Walk.

Published in:

2022

By:

Hershey, Andrew

Publication type:

Editorial

Effect of antibody switch in non-responders to a CGRP receptor antibody treatment in migraine: A multi-center retrospective cohort study.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 291, doi. 10.1177/03331024211048765

By:

Overeem, Lucas Hendrik;
Peikert, Andreas;
Hofacker, Maxi Dana;
Kamm, Katharina;
Ruscheweyh, Ruth;
Gendolla, Astrid;
Raffaelli, Bianca;
Reuter, Uwe;
Neeb, Lars

Publication type:

Article

Incidence of spontaneous intracranial hypotension in a community: Beverly Hills, California, 2006–2020.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 312, doi. 10.1177/03331024211048510

By:

Schievink, Wouter I;
Maya, M Marcel;
Moser, Franklin G;
Simon, Paul;
Nuño, Miriam

Publication type:

Article

T2* reduction in patients with acute post-traumatic headache.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 357, doi. 10.1177/03331024211048509

By:

Nikolova, Simona;
Schwedt, Todd J;
Li, Jing;
Wu, Teresa;
Dumkrieger, Gina M;
Ross, Katherine B;
Berisha, Visar;
Chong, Catherine D.

Publication type:

Article

TOP-PRO study: A randomized double-blind controlled trial of topiramate versus propranolol for prevention of chronic migraine.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 396, doi. 10.1177/03331024211047454

By:

Chowdhury, Debashish;
Bansal, Luv;
Duggal, Ashish;
Datta, Debabrata;
Mundra, Ankit;
Krishnan, Anand;
Koul, Arun;
Gupta, Anu

Publication type:

Article

Clinical correlates of hypothalamic functional changes in migraine patients.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 279, doi. 10.1177/03331024211046618

By:

Messina, Roberta;
Rocca, Maria A;
Valsasina, Paola;
Misci, Paolo;
Filippi, Massimo

Publication type:

Article

Migraine evolution after the cessation of CGRP(-receptor) antibody prophylaxis: a prospective, longitudinal cohort study.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 326, doi. 10.1177/03331024211046617

By:

Raffaelli, Bianca;
Terhart, Maria;
Overeem, Lucas Hendrik;
Mecklenburg, Jasper;
Neeb, Lars;
Steinicke, Maureen;
Reuter, Uwe

Publication type:

Article

No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 335, doi. 10.1177/03331024211045653

By:

Naegel, Steffen;
Zeller, Julia;
Hougard, Anders;
Weise, Christopher Michael;
Zuelow, Stefan;
Kleinschnitz, Christoph;
Obermann, Mark;
Solbach, Kasja;
Holle, Dagny

Publication type:

Article

Polygenic risk provides biological validity for the ICHD-3 criteria among Finnish migraine families.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 345, doi. 10.1177/03331024211045651

By:

Häppölä, Paavo;
Gormley, Padhraig;
Nuottamo, Marjo E;
Artto, Ville;
Sumelahti, Marja-Liisa;
Nissilä, Markku;
Keski-Säntti, Petra;
Ilmavirta, Matti;
Kaunisto, Mari A;
Hämäläinen, Eija I;
Ripatti, Samuli;
Pirinen, Matti;
Wessman, Maija;
Palotie, Aarno;
Kallela, Mikko

Publication type:

Article

Greater occipital nerve block in migraine may have a place in migraine treatment.

Published in:

2022

By:

İnan, Levent Ertuğrul;
İnan, Nurten

Publication type:

Letter to the Editor

The influence of endogenous and exogenous hormonal factors on migraine in spontaneous postmenopausal women: A nationwide population-based study in South Korea.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 376, doi. 10.1177/03331024211044441

By:

Kim, Seonghoon;
Lee, Si Baek;
Hong, Yun Jeong;
Kim, Yongbang;
Han, Kyungdo;
Park, Jeong Wook

Publication type:

Article

Time to retire 'New daily persistent headache': Mode of onset of chronic migraine and tension-type headache.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 385, doi. 10.1177/03331024211044440

By:

Lobo, Rhannon;
Wang, Mu;
Lobo, Sean;
Bahra, Anish

Publication type:

Article

Indirect costs attributed to headache: A nation-wide survey of an active working population.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 317, doi. 10.1177/03331024211043795

By:

Gil-Gouveia, Raquel;
Miranda, Raquel

Publication type:

Article

Headache in progressive facial hemiatrophy (Parry-Romberg syndrome): A paradigmatic case and systematic review of the literature.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 409, doi. 10.1177/03331024211043452

By:

Foiadelli, Thomas;
Rossi, Alessandra;
Trabatti, Chiara;
Spreafico, Eugenia;
Santi, Viola;
Orsini, Alessandro;
Verrotti, Alberto;
Savasta, Salvatore

Publication type:

Article

The characteristics of COVID-19 vaccine-related headache: Clues gathered from the healthcare personnel in the pandemic.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 366, doi. 10.1177/03331024211042390

By:

Ekizoglu, Esme;
Gezegen, Haşim;
Yalınay Dikmen, Pınar;
Orhan, Elif Kocasoy;
Ertaş, Mustafa;
Baykan, Betül

Publication type:

Article

Efficacy and safety of exogenous beta-hydroxybutyrate for preventive treatment in episodic migraine: A single-centred, randomised, placebo-controlled, double-blind crossover trial.

Published in:

Cephalalgia, 2022, v. 42, n. 4/5, p. 302, doi. 10.1177/03331024211043792

By:

Putananickal, Niveditha;
Gross, Elena C;
Orsini, Anna-Lena;
Schmidt, Simone;
Hafner, Patricia;
Gocheva, Vanya;
Nagy, Sara;
Henzi, Bettina C;
Rubino, Daniela;
Vogt, Deborah R;
Cichon, Sven;
Sandor, Peter;
Fischer, Dirk

Publication type:

Article